AcrySof® Vivity Edof

AcrySof IQ Vivity IOL Early Experience Meeting

acrysof iq vivity first user certificate

Transcription:
Blue Eye Milan, 5 December 2019: we had the honor of having to experience and explore the innovative Vivity IOL with its Wavefront-Shaping technology.

The company that proposes this lens has invested heavily in research and we finally have a lens that seems to be very innovative. Such innovation of the lens is consistent with the depth of focus of the lens itself, so it has an ability to focus images not only from afar but also intermediate and partly peripheral focus, without creating any kind of side effect.

The trifocal lenses that we are used to and the old generation bifocal lenses are well used in near vision but in some patients, side effects, such as halos around lights, occur.

This new kind of lens is instead superimposable, has a great advantage for having a strong intermediate focus, so the patient is not obliged to use corrections when using the computer, therefore a good number of patients have sufficient strength to see up close without the use of eyeglasses.

The technology is that of stretch & shift, which consists of having to extend the focal range and having it shifted to the useful part (often, the focus of a lens is positioned beyond the vision from afar and in the middle towards near vision); having shifted the focus to the peripheral area and having to extend it, the focus of the lens is thereby indeed useful to the patient.


acrysof iq vivity trifocal dr alberto bellone acrysof iq vivity trifocal dr bellone acrysof iq vivity trifocal alberto bellone

Dear. Doc. Bellone,

 

You are cordially invited to the AcrySof® IQ Vivity IOL Early Experience Meeting. The pre-launch meeting will be hosted on Friday, November 15th, from 8:30am to 13:30pm at the Alcon Experience Center in Barcelona, Spain.

As part of this program, we will explore the innovative Wavefront-Shaping technology behind the AcrySof® IQ Vivity IOL and see how it creates an extended focal range with the halo and glare profile of a monofocal. I hope you are as excited as we are by the opportunity to bring this unique new presbyopia-correcting IOL to you and your patients.

Thank you for your contribution to the AcrySof® IQ Vivity IOL and for your ongoing partnership with Alcon. Your commitment and expertise are invaluable to our dedicated effort to help patients leave halo and glare behind.

 

Sincerely,

Daniela Kustermann
Surgical Product Manager


AcrySof IQ Vivity IOL Early Experience Meeting

Download PDF

AcrySof IQ Vivity IOL Early Experience Meeting

This post is also available in: Italian